北美 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术（实时 PCR、常规 PCR、逆转录 PCR、数字 PCR、多重 RT PCR、热启动 PCR 等）、产品（试剂和耗材、仪器、软件和服务）、应用（基因表达分析、基因测序、基因分型、核酸合成、标准验证、即时诊断、环境应用等）和最终用户（医院和诊断中心、学术和研究机构、制药和生物技术公司等）划分
PCR 技术的进步推动北美 PCR 技术市场发展
PCR 的优势（例如灵敏性、相对简单和成本效益）在过去几年中极大地增加了它的普及度。PCR 技术已经发生了显着的变化，为各种应用提供了更具体的工作流程。PCR 技术的应用正在探索到几种非常规应用中，使分子诊断更容易、更快捷。dPCR 和 RT-PCR 的进步用于诊断疾病、识别病毒和细菌以及辅助法医调查。研究人员正试图使用一些纳米材料来缩短测试时间。 2023 年 3 月，韩国科学技术研究院 (KIST) 的智能传感增强安全系统中心宣布开发超快速 PCR 技术。该开发项目由 Sang Kyung Kim 博士（主任）和 Seungwon Jung 博士的研究团队领导。超快速 PCR 利用光热纳米材料，将测试时间缩短了 10 倍，与之前的测试相比。新方法的诊断性能与现有测试方法相当，可在 5 分钟内完成。2021 年 1 月，丹纳赫公司宣布加拿大卫生部向 Cepheid 颁发了 Xpert Xpress SARS-CoV-2/Flu/RSV 的医疗器械许可证。PCR 技术市场中的一些公司取得了技术进步，2021 年 3 月，PCR Biosystems 宣布推出其 IsoFast Bst 聚合酶试剂，该试剂支持灵敏、稳健和快速的 RNA 和 DNA 扩增，从而加快了检测程序。 2021 年 10 月，赛默飞世尔科技推出了 Applied Biosystem Quantstudio Absolute Q-Digital PCR 系统，这是第一款完全集成的 dPCR 系统，旨在提供高度准确和一致的基因分析。该公司声称该产品可在 90 分钟内产生研究结果。2022 年 5 月，Bio-Rad Laboratories, Inc. 在接受 CE 标志的选定国家推出了其 CFX Duet Real-Time PCR 系统。该系统旨在支持研究人员开发单重和双重 qPCR 检测。2022 年 11 月，PCR Biosystems 推出了新的 qPCR 试剂混合物——Clara Probe Mix、Clara Probe 1-Step Mix 和 Clara HRM Mix。2022 年 11 月，Cepheid 推出了 Xpert Xpress MVP 多重 PCR 测试。该检测有助于从单个样本中检测出与三种不同疾病（即细菌性阴道病 (BV)、滴虫病和外阴阴道念珠菌病）相关的生物体的 DNA，有助于更精确的诊断并支持准确的抗生素治疗方案。因此，预计此类进步将在未来几年为 PCR 技术市场带来新的趋势。
北美 PCR 技术市场概览
北美 PCR 技术市场分为美国、加拿大和墨西哥。该地区的市场增长归因于生物分析仪器制造商和 PCR 公司对创新产品的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。此外，在医疗保健运营中采用医疗设备以提高质量和降低成本的众所周知的做法也使美国和其他北美国家的 PCR 技术市场受益。随着基因合成和编辑工具（如 CRISPR 和 PCR）在研究和治疗中的接受度和采用度不断上升，需要能够帮助快速量化、改变和观察的检测方法。数字 PCR 以液滴数字 PCR 的形式出现，为筛选提供了新的机会，具有出色的灵敏度和易适应性。美国正在寻求公共和私人组织的大量资金，以鼓励对先进研究方法的投资。例如，国际遗传工程和生物技术中心旨在促进成员国的合作研究。它通过合作研究计划 (CRP) 获得资金，旨在解决相关和感兴趣的原始科学问题。依赖 PCR 技术的生物技术进步有助于改善人类健康、动物福利和粮食安全。美国食品药品监督管理局 (USFDA) 致力于确保生物技术产品的安全。美国积极参与各种研究团体和组织举办科学会议、研讨会和活动，帮助交流不同地区基于 PCR 的趋势和最新研究成果。因此，该国的积极参与也是推动 PCR 技术市场增长的因素之一。
北美 PCR 技术市场收入及预测至 2030 年（百万美元）
北美 PCR 技术市场细分
北美 PCR 技术市场细分为技术、产品、应用、最终用户和国家。
基于技术，北美 PCR 技术市场细分为实时 PCR、常规 PCR、逆转录、数字 PCR、多重 RTPCR、热启动 PCR 等。实时 PCR 细分市场在 2022 年占据了北美 PCR 技术市场的最大份额。
在产品方面，北美 PCR 技术市场分为试剂和耗材、仪器以及软件和服务。试剂和耗材部分在 2022 年占据北美 PCR 技术市场的最大份额。此外，试剂和耗材部分分为试剂、小瓶大小和其他耗材。此外，小瓶大小分为 0.2 毫升至 2 毫升、0.1 毫升至 0.3 毫升、2 毫升至 5 毫升和其他小瓶。此外，仪器部分分为台式 PCR 和便携式热循环仪/PCR。
根据应用，北美 PCR 技术市场细分为基因表达分析、基因测序、基因分型、核酸合成、标准验证、即时诊断应用、环境应用等。基因表达分析部分在 2022 年占据北美 PCR 技术市场的最大份额。
根据最终用户，北美 PCR 技术市场分为医院和诊断中心、制药和生物技术公司、学术机构和研究实验室等。 2022 年，医院和诊断中心部门占据了北美 PCR 技术市场的最大份额。
按国家/地区划分，北美 PCR 技术市场分为美国、加拿大和墨西哥。2022 年，美国主导了北美 PCR 技术市场。
Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Atila Biosystems Inc、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Visby Medical Inc 和 Ellume Ltd 是北美 PCR 技术市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America PCR Technologies Market - Key Industry Dynamics
4.1 PCR Technologies Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market - North America Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030
6. North America PCR Technologies Market Analysis - By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. North America PCR Technologies Market Analysis - By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. North America PCR Technologies Market Analysis - By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. North America PCR Technologies Market Analysis - By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. North America PCR Technologies Market - Country Analysis
10.1 North America: PCR Technologies Market
10.1.1 Overview
10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
10.1.2.1 United States
10.1.2.1.1 Overview
10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
10.1.2.3 Canada
10.1.2.3.1 Overview
10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
10.1.2.5 Mexico
10.1.2.5.1 Overview
10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Atila Biosystems Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Takara Bio Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Standard Biotools Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Agilent Technologies Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Visby Medical Inc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Ellume Ltd
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
Table 9. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 10. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 11. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 12. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 13. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 14. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 15. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 16. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 17. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 18. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 19. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 20. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 21. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 22. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 23. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
Table 24. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
Table 25. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
Table 26. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
Table 27. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
Table 28. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
Table 29. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
Table 32. Glossary of Terms, PCR Technologies Market
List of Figures
Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. North America: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
Figure 31. North America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 33. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 34. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
Figure 35. Growth Strategies in the PCR Technologies Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Atila Biosystems Inc
9. Takara Bio Inc
10. Standard BioTools Inc
11. Agilent Technologies Inc
12. Visby Medical Inc
13. Ellume Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America PCR technologies market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.